Background:
In addition to conventional breast-conserving surgery (BCS), oncoplastic breast surgery
(OBS) is an operation technique that strives simultaneously to increase oncological
safety and patient's satisfaction. It is the combination of the best-proven techniques
in plastic surgery with surgery for breast cancer. In a growing number of indications,
OBS overcomes the limit of conventional BCS by allowing larger resection volumes while
avoiding deformities. The aim of our retrospective study (2012 to 2014) was to compare
oncological outcomes of OBS versus BCS.
Patients and methods:
We compared two groups of patients with primary non-metastatic breast tumours: group
A (n = 291), where BCS was performed, versus group B (n = 52), where OBS was performed.
Surgical interventions were performed in German and Swiss teaching hospital settings.
The surgeon for group B had subspecialist training in OBS. We assessed outcome in
term of re-excision rates, resection margin and complications.
Results:
Groups were homogenous (no significant differences in terms of age, tumour size, tumour
type or grade). The resection margin was larger in Group B (7 mm) than in Group A
(3 mm). Re-excision rate of Group B (8%) was significantly lower than in the Group
A (31%). Complication rates were comparably low in groups A and B.
Conclusion:
Our results confirm that oncoplastic breast surgery is safe and reduces the re-excision
rates and the need for further surgery. Moreover, OBS permits extensive resections
of breast parenchyma for treatment of breast cancer, achieves clear tumour margins
and avoids the need for further surgery.
